World's Best Scientists 2026 revealed!
Robert D. Inman

Robert D. Inman

Award Badge
Immunology
Canada
2025

D-Index & Metrics

Immunology

D-Index
97
Citations
34945
World Ranking
823
National Ranking
13

Medicine

D-Index
99
Citations
36424
World Ranking
8591
National Ranking
336

Research.com Recognitions

  • 2025 - Research.com Immunology in Canada Leader Award

Overview

Robert D. Inman is affiliated with the University of Toronto in Canada and focuses primarily on the field of Medicine, with a substantial number of publications in Rheumatology, Immunology, Molecular Biology, Psychiatry and Mental Health, and Hematology. Their research covers a range of topics related to autoimmune and inflammatory diseases, spondyloarthritis, and musculoskeletal conditions.

Their recent papers highlight contributions across immunology and rheumatology, including studies on COVID-19 susceptibility, ankylosing spondylitis, and immune response mechanisms. Notable recent publications include:

  • HLA, Immune Response, and Susceptibility to COVID-19, 2021, Frontiers in Immunology
  • Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial, 2022, Annals of the Rheumatic Diseases
  • Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature, 2023, Annals of the Rheumatic Diseases
  • TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis, 2020, Journal of Clinical Investigation
  • Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease, 2021, Science Translational Medicine

Robert D. Inman frequently collaborates with several researchers, with the most prolific coauthors being:

  • Nigil Haroon (29 joint publications)
  • Sherry Rohekar (9 joint publications)
  • Fataneh Tavasolian (8 joint publications)
  • Dafna D. Gladman (8 joint publications)
  • Joachim Sieper (7 joint publications)

The most common venues for publishing their work include:

  • Annals of the Rheumatic Diseases (15 publications)
  • The Journal of Rheumatology (8 publications)
  • Arthritis Research & Therapy (6 publications)
  • Lara D. Veeken (4 publications)
  • Pain (3 publications)

Their book publications with Princeton University Press feature two editions of "Democratic Federalism" released in 2020.

Main topics of Robert D. Inman's research cover:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Rheumatoid Arthritis Research and Therapies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Autoimmune and Inflammatory Disorders Research
  • Inflammasome and immune disorders
  • Musculoskeletal pain and rehabilitation

Best Publications

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

    John C. Davis;Désirée Van Der Heijde;Jurgen Braun;Maxime Dougados

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.

    Robert D. Inman;John C. Davis;Désirée Van Der Heijde;Laura Diekman

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Molecular Mimicry and Autoimmunity

    Lori J. Albert;Robert D. Inman

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    John D. Reveille;Anne Marie Sims;Patrick Danoy;David M. Evans

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

    Nigil Haroon;Robert D. Inman;Thomas J. Learch;Michael H. Weisman

  • Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis

    Walter P. Maksymowych;Robert D. Inman;David Salonen;Suhkvinder S. Dhillon

  • 2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Braun;R. Van Den Berg;X. Baraliakos;H. Boehm

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

  • Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

    James B. Bussel;Robert P. Kimberly;Robert D. Inman;Irving Schulman

  • Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

    Robert G W Lambert;David Salonen;Proton Rahman;Robert D Inman

  • Pathogenesis of ankylosing spondylitis — recent advances and future directions

    Vidya Ranganathan;Eric Gracey;Eric Gracey;Matthew A. Brown;Robert D. Inman

  • Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

    Adrian Cortes;Sara L. Pulit;Paul J. Leo;Jenny J. Pointon

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    A. Cortes;J. Hadler;J.P. Pointon;P.C. Robinson

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    J. D. Reveille;A. M. Sims;P. Danoy;D. M. Evans

Frequent Co-Authors

Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Michael H. Weisman
Michael H. Weisman Cedars-Sinai Medical Center
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
David Evans
David Evans University of Bristol
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Robert Landewé
Robert Landewé University of Amsterdam
Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Karen D. Davis
Karen D. Davis University Health Network

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various related healthcare careers, many of which can be pursued through flexible online programs. For those interested in entering the nursing field quickly, finding accredited LPN programs easy to get into offers a practical start. These programs provide essential clinical skills and a solid foundation for advancing in patient care roles.

For advanced practice, nursing students should consider programs like the easiest nurse practitioner program, which balance accessibility with quality education. These programs prepare graduates for increased responsibilities in diverse clinical settings.

Specializing further, the best PMHNP programs online offer excellent clinical placement support for students focusing on psychiatric and mental health nursing. These programs are ideal for those aiming to make a difference in mental healthcare through evidence-based immunological and psychiatric knowledge.

Cost is often a deciding factor when choosing a program. Prospective students can explore the cheapest psych NP programs that maintain accreditation and clinical rigor, making advanced degrees in psychiatric nursing more accessible without compromising quality.

Best Scientists Citing Robert D. Inman

Trending Scientists

Recently Published Articles